[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336057-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336057-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","nmr-and-ms-reveal-characteristic-metabolome-atlas-and-optimize-esophageal-squamous-cell-carcinoma-early-detection","NMR and MS reveal characteristic metabolome atlas and optimize esophageal squamous cell carcinoma early detection","","Metabolic changes precede malignant histology, yet the existence of detectable characteristic metabolomic signatures in esophageal squamous cell carcinoma (ESCC) tissues and biofluids for early diagnosis remains unclear. Using NMR- and MS-based metabolomics on 1,153 matched ESCC tissues plus normal mucosa and pre-/one-week post-operative sera and urine from 560 participants across three hospitals, the study applies machine learning and WGCNA. Alanine, aspartate and glutamate metabolism aberrations are pervasive and yield serum and urine metabolic signatures. Simplified five-metabolite NMR panels outperform clinical tumor markers, accurately distinguishing early-stage ESCC.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/nmr-and-ms-reveal-characteristic-metabolome-atlas-and-optimize-esophageal-squamous-cell-carcinoma-early-detection/336057/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/nmr-and-ms-reveal-characteristic-metabolome-atlas-and-optimize-esophageal-squamous-cell-carcinoma-early-detection/336057.png","ImageObject",300,407,{"name":42,"@type":43},"Finn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What gap does the study address in ESCC early diagnosis?","Question",{"text":63,"@type":64},"It addresses whether characteristic, detectable metabolomic changes exist in ESCC tissues and biofluids that can enable early diagnosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the metabolomics analysis performed?",{"text":68,"@type":64},"The study used NMR- and MS-based metabolomics on matched ESCC tissues, normal mucosa, and pre-/one-week post-operative sera and urine, combined with machine learning and WGCNA.",{"name":70,"@type":61,"acceptedAnswer":71},"Which metabolic pathway changes are emphasized?",{"text":72,"@type":64},"Aberrations in alanine, aspartate and glutamate metabolism are reported as prevalent throughout ESCC evolution and consistently identified by both NMR and MS.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336057,1790100854,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","Article [https://doi.org/10.1038/s41467-024-46837-0](https://doi.org/10.1038/s41467-024-46837-0)  \nNMR and MS reveal characteristic metabolome atlas and optimize esophageal squamous cell carcinoma early detection  \nReceived: 29 August 2023  \n\n| Accepted: 6 March 2024 |\n| --- |\n| |\n| Check for updates |\n\nYan Zhao 1,2,6, Changchun Ma3,6, Rongzhi Cai1, Lijing Xin 4, Yongsheng Li 5, Lixin Ke1, Wei Ye1, Ting Ouyang1, Jiahao Liang1, Renhua Wu 1,7  &Yan Lin 1,7   \nMetabolic changes precede malignant histology. However, it remains unclear whether detectable characteristic metabolome exists in esophageal squamous cell carcinoma (ESCC) tissues and bioﬂuids for early diagnosis. Here, we conduct NMR-and MS-based metabolomics on 1,153 matched ESCC tissues, normal mucosae, pre-and one-week post-operative sera and urines from 560 participants across three hospitals, with machine learning and WGCNA. Aberrations in ‘alanine, aspartate and glutamate metabolism’ proved to be prevalent throughout the ESCC evolution, consistently identiﬁed by NMR and MS, and reﬂected in 16 serum and 10 urine metabolic signatures in both discovery and validation sets. NMR-based simpliﬁed panels of any ﬁve serum or urine metabolites outperform clinical serological tumor markers (AUC = 0.984 and0.930, respectively), and are effective in distinguishing early-stage ESCCin test set (serum accuracy = 0.994, urine accuracy = 0.879). Collectively, NMRbased bioﬂuid screening can reveal characteristic metabolic events of ESCCand be feasible for early detection (ChiCTR2300073613).  \nEsophageal cancer (EC) is a signiﬁcant public health concern worldwide1. China accounts for over half ofthe global annual incidence and mortality, of which more than 90% are esophageal squamous cell carcinoma (ESCC), and the T0, Tis, and T1 stages account for 10.8% of the total cases2,3. The cure rate for early-stage ESCC exceeds 90%. However, due to the subtle nature of symptoms and the lack of biomarkers for early diagnosis, most patients are typically diagnosed in late-stage T3-T4, resulting in a 5-year survival rate of only approximately 21%4. Currently, the gold standard for diagnosing ESCC primarily relies on endoscopy coupled with histopathology, but its invasive nature reduces patient compliance5. Barium swallow and CT imaging techniques involve radiation exposure and tend to miss small lesions. Conventional serological tumor markers, such as Cytokeratin- 19-fragment CYFRA21-1 (Crfr211), Squamous Cell Carcinoma Antigen (SCC), Carcinoembryonic Antigen (CEA), Carbohydrate Antigen 19-9  \n(CA 19-9) and Carbohydrate Antigen 15-3 (CA 15-3) have shown suboptimal accuracy in clinical practice. With the advancements in omics technologies, researchers have explored several novel biomarkers for ESCC diagnosis, including DNA methylation markers, serum miRNA, autoantibodies, somatic gene mutations, salivary exosomes, and artiﬁcial intelligence (AI)-assisted sponge cytology6–11. However, these approaches face limitations due to the requirement of advanced technology platforms, methodological instability, or high costs, hindering their translation into large-scale clinical applications. Consequently, there is an urgent need to develop reliable, non-invasive, accessible and affordable tools for ESCC early detection12.  \nIt takes years for ESCC to progress from squamous cell hyperplasia to atypical hyperplasia, carcinoma in situ, early-stage and invasive cancer13. In addition, metabolic phenotypic changes could precede malignant histological alterations, providing a signiﬁcant  \n1Radiology Department, Second Afﬁliated Hospital of Shantou University Medical College, Shantou, Guangdong, China. 2Central Laboratory, Clinical Research Center, Shantou Central Hospital, Shantou, Guangdong, China. 3Radiation Oncology Department, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China. 4Animal Imaging and Technology Core, Center for Biomedical Imaging, Ecole Polytechnique Fédérale de Lausan","cbCaikTktrvJ3GTi","https://ap.wps.com/l/cbCaikTktrvJ3GTi","pdf",15344745,17,"English","# Background\n## Clinical need and limitations of current diagnostics\n## Metabolomics rationale and platforms\n# Study design and methods\n## Cohort, sampling, and metabolomics workflow\n## Machine learning and WGCNA\n# Results\n## Alanine, aspartate and glutamate metabolism across ESCC evolution\n## Discovery and validation serum/urine signatures\n## Performance of simplified NMR panels vs tumor markers\n# Implications\n## Feasibility of biofluid screening for early detection","[{\"question\":\"What gap does the study address in ESCC early diagnosis?\",\"answer\":\"It addresses whether characteristic, detectable metabolomic changes exist in ESCC tissues and biofluids that can enable early diagnosis.\"},{\"question\":\"How was the metabolomics analysis performed?\",\"answer\":\"The study used NMR- and MS-based metabolomics on matched ESCC tissues, normal mucosa, and pre-/one-week post-operative sera and urine, combined with machine learning and WGCNA.\"},{\"question\":\"Which metabolic pathway changes are emphasized?\",\"answer\":\"Aberrations in alanine, aspartate and glutamate metabolism are reported as prevalent throughout ESCC evolution and consistently identified by both NMR and MS.\"}]","NMR and MS reveal characteristic metabolome atlas and optimize esophageal squamous cell carcinoma early detection | PDF",1790013416,43]